Chief Research Officer
Steven L. Bernstein, MD, has been named as the inaugural Chief Research Officer for Dartmouth-Hitchcock (D-H), Associate Dean of Clinical Research and Director of the C. Everett Koop Institute at the Geisel School of Medicine at Dartmouth.
As Chief Research Officer, Dr. Bernstein will oversee all aspects of research at D-H, including serving as the designated Institutional Official for Research, leading D-H's Office of Research Operations, and overseeing development and implementation of a forward-looking strategic plan for growth of the organization's clinical, translational and population-based research portfolio. As Associate Dean for Clinical Research for Geisel, Dr. Bernstein is responsible for growing and supporting the school's clinical and translational research programs, and, working with colleagues from across D-H and Dartmouth College, will develop opportunities and processes for clinical and translational research that span our organizations. In his role as Director of the C. Everett Koop Institute, Dr. Bernstein will lead the Institute's efforts to advance health and well-being through research, education and policy activities to protect the public health and prevent disease. The Institute seeks to mitigate threats posed by the unhealthy promotion and use of consumer products, including tobacco, alcohol and highly processed foods, as well as prescription drugs.
Dr. Bernstein previously served as Professor and Vice Chair of Research in the Department of Emergency Medicine at the Yale School of Medicine and Professor of Public Health (Chronic Disease Epidemiology) in the Yale School of Public Health. In those roles he developed screening and treatment interventions for tobacco users in hospital settings, and programs to train providers in tobacco control.
Dr. Bernstein holds a bachelor's degree from Princeton University, and he earned his medical degree from the Temple University School of Medicine. He trained in residencies at SUNY Health Sciences Center in New York and at Long Island Jewish Medical Center. Dr. Bernstein was a fellow in hematology-oncology at SUNY Health Sciences Center and was a visiting fellow in clinical epidemiology at the Robert Wood Johnson Clinical Scholars Program at Yale.
Dr. Bernstein's research has received funding from a broad range of agencies, including the National Institute on Drug Abuse, the Centers for Disease Control and Prevention, the Agency for Healthcare Research and Quality, the Robert Wood Johnson Foundation, and other agencies and foundations. His work has appeared in journals as diverse as Health Affairs, the American Journal of Public Health, Annals of Emergency Medicine and Nicotine and Tobacco Research. He has strong interests in implementation science and is the founding Director of the Yale Center for Implementation Science. Current work includes studying the efficacy of a brief counseling intervention, nicotine replacement therapy, a telephone quit line service and an SMS texting program in helping adult smokers in the emergency department quit tobacco. Dr. Bernstein is also involved in a project using network analysis to model patterns of adherence and abstinence in human health behavior. He has additional interests in teaching the principles of public health, population health and prevention to medical students, residents and practitioners.